NCT02151578 (HMM/P) is a Phase 4 clinical trial of home/community case management in Malaria, sponsored by World Health Organization.

Who is sponsoring NCT02151578?

NCT02151578 is sponsored by World Health Organization.

What drugs are being tested in NCT02151578?

Interventions in NCT02151578: home/community case management.

What condition does NCT02151578 study?

NCT02151578 studies Malaria, Pneumonia.

Is NCT02151578 still recruiting?

NCT02151578 is currently completed. Last updated 29 May 2014.

Last reviewed 2014-05-29 · How we verify

NCT02151578: HMM/P

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Home and Community Management of Fevers/Malaria and Pneumonia in Children Under-five: a Cluster Randomised Controlled Trial of an Integrated Approach in a Rural District of Burkina Faso

Completed Phase 4 Last updated 29 May 2014

What this trial tests

Phase 4 trial testing home/community case management in Malaria in 11,500 participants. Completed in 1 September 2012.

Timeline

1 January 2009

Primary endpoint
1 June 2012

1 September 2012

Quick facts

Lead sponsor	World Health Organization
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	11,500
Start date	1 January 2009
Primary completion	1 June 2012
Estimated completion	1 September 2012
Sites	1 location across Burkina Faso

Drugs / interventions tested

home/community case management

Conditions studied

Malaria — all drugs for Malaria →
Pneumonia — all drugs for Pneumonia →

Sponsor

World Health Organization

Who can join

Adults 6 Months to 59 Months, any sex, with Malaria or Pneumonia. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Number of death in children aged 6 to 59 months
Time frame: 12 months
annual crude mortality rate in children aged 0 to 6 months in the different study arms

Sponsor's own description

A well-implemented community-based program of early and appropriate treatment of fevers/malaria episodes and pneumonia,will improve child survival as measured by a reduction of the less than five mortality rate.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Integrated community case management of childhood illness in low- and middle-income countries.
Oliphant NP, Manda S, Daniels K, Odendaal WA, et al · · 2021 · cited 32× · PMID 33565123 · DOI 10.1002/14651858.cd012882.pub2

Verify or expand the search:

Other recruiting trials for Malaria

Currently open trials in the same condition.

NCT07358910 — Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective · recruiting
NCT07036159 — A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months · Phase 2 · recruiting
NCT06735209 — First-in-Human PfSPZ-LARC2 Vaccination/CHMI · Phase 1 · active not recruiting
NCT06854042 — A Study of Oral E1018 in Healthy Adult Participants · Phase 1 · recruiting
NCT06607003 — Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Cha · Phase 1 · recruiting

Other World Health Organization trials

Trials by the same sponsor.

NCT07116447 — Impact of Alcohol Health Messages in a Real-world Online Retail Setting · NA · completed
NCT06915298 — Impact of Alcohol Labels in a Real-World Setting · NA · completed
NCT06090006 — An Adolescent Health and Wellbeing Check-up Programme in Three African Cities (Y-Check) · NA · unknown
NCT03752112 — Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis in Non-pregnant Women · Phase 1, PHASE2 · unknown
NCT03130114 — Antibiotics for Children With Severe Diarrhoea · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02151578 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by World Health Organization
Last refreshed: 29 May 2014

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02151578.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing